Learn how physicians are turning to DIY medicine education to improve patient care and outcomes amid the physician shortage and long wait times for treatment.

MAXONA Pharmaceuticals today announced the preliminary results of the Phase 1 clinical program for MAX-001, which is in development as a New Molecular Entity (NME), non-opioid, non-NSAID oral therapy ...